McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (2019)
Memantine for dementia
Cochrane Database Syst Rev 3: CD003154
Ringman JM, Schneider L (2019)
Treatment Options for Agitation in Dementia
Curr Treat Options Neurol 21: 30
Katz FS, Pecic S, Schneider L, Zhu Z, Hastings A, Luzac M, MacDonald J, Landry DW, Stojanovic MN (2018)
New therapeutic approaches and novel alternatives for organophosphate toxicity
Toxicol Lett 291: 1
Lang D, Ullrich KK, Murat F, Fuchs J, Jenkins J, Haas FB, Piednoel M, Gundlach H, Van Bel M, Meyberg R, Vives C, Morata J, Symeonidi A, Hiss M, Muchero W, Kamisugi Y, Saleh O, Blanc G, Decker EL, van Gessel N, Grimwood J, Hayes RD, Graham SW, Gunter LE, McDaniel SF, Hoernstein SNW, Larsson A, Li FW, Perroud PF, Phillips J, Ranjan P, Rokshar DS, Rothfels CJ, Schneider L, Shu S, Stevenson DW, Thummler F, Tillich M, Villarreal Aguilar JC, Widiez T, Wong GK, Wymore A, Zhang Y, Zimmer AD, Quatrano RS, Mayer KFX, Goodstein D, Casacuberta JM, Vandepoele K, Reski R, Cuming AC, Tuskan GA, Maumus F, Salse J, Schmutz J, Rensing SA (2018)
The Physcomitrella patens chromosome-scale assembly reveals moss genome structure and evolution
Plant J 93: 515
Katz FS, Pecic S, Tran TH, Trakht I, Schneider L, Zhu Z, Ton-That L, Luzac M, Zlatanic V, Damera S, MacDonald J, Landry DW, Tong L, Stojanovic MN (2015)
Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates
Chembiochem 16: 2205
Katz FS, Pecic S, Tran TH, Trakht I, Schneider L, Zhu Z, Ton-That L, Luzac M, Zlatanic V, Damera S, MacDonald J, Landry DW, Tong L, Stojanovic MN (2015)
Cover Picture: Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates (ChemBioChem 15/2015)
Chembiochem 16: 2113
Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA (2008)
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis
Critical Care Medicine 36: 404
Lopez-Arrieta JM, Schneider L (2006)
Metrifonate for Alzheimer's disease
Cochrane Database Syst Rev
Loy C, Schneider L (2006)
Galantamine for Alzheimer's disease and mild cognitive impairment
Cochrane Database Syst Rev
Cummings JL, Schneider L, Tariot PN, Kershaw PR, Yuan W (2004)
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease
Am J Psychiatry 161: 532
Loy C, Schneider L (2004)
Galantamine for Alzheimer's disease
Cochrane Database Syst Rev
Olin J, Schneider L (2002)
Galantamine for Alzheimer's disease (Cochrane Review)
Cochrane Database Syst Rev
Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, Schneider L, Takeda M, Tariot P, Wilkinson D (2001)
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
Int J Geriatr Psychiatry 16: 653
Sands LP, Katz I, Schneider L (1999)
Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors
Alzheimer Disease & Associated Disorders 13: 26
Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL (1998)
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
Neurology 50: 669
Knopman D, Schneider L, Davis K, Gracon S, Smith F (1998)
Long-term tacrine treatment effects
Neurology 50: 567
Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M (1998)
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration
Jama 280: 1777
Tariot PN, Schneider L, Porsteinsson AP (1997)
Treating Alzheimer's disease.Pharmacologic options now and in the near future
Postgrad Med 101: 73
Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S (1996)
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group
Neurology 47: 166